Dosing & Uses
AdultPediatric
Single Ventricle Heart Disease
Pending FDA approval for patients aged ≥12 years with single ventricle heart disease who have undergone the Fontan operation
Single Ventricle Heart Disease
Pending FDA approval for patients aged ≥12 years with single ventricle heart disease who have undergone the Fontan operation
<12 years: Safety and efficacy not established
Next:
Pharmacology
Mechanism of Action
Inhibits PDE-5, increasing cyclic guanosine monophosphate cGMP to allow smooth-muscle relaxation
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
